June 26, 2026 — Jinhe Biotechnology Co., Ltd. said its board voted 9-0 to
approve investment in a flexible production project with annual capacity of
10,000 tonnes of gramicidin and 20,000 tonnes of coenzyme Q10 intermediates.
Total investment is about RMB 549.57 million, to be funded by the company’s own
funds or self-raised financing.